ZeptoMetrix, an Antylia Scientific company, has launched the NATtrol Bacteriophage MS2 quantitative stock, NATMS2-STQ, which is intended for use as an internal process control for molecular diagnostic assays.

Bacteriophage MS2 is a virus that infects Escherichia coli bacteria and other members of the Enterobacteria family. It has proven utility as an internal process control for RT-PCR assays. NATtrol inactivation of MS2 results in a refrigerator-stable, whole organism stock solution which shows increased reproducibility and lot-to-lot consistency over live MS2, making it an ideal internal control for rt-PCR assays.  

“The combination of our dedicated scientific consulting team and our innovative materials for assay development make ZeptoMetrix the partner of choice for molecular diagnostics developers,” says Evangeline Gonzalez, vice president/general manager of ZeptoMetrix. “The addition of the NATtrol MS2 is another great example of our commitment to the MDx industry.”

ZeptoMetrix’s expertise in molecular diagnostics includes external quality controls, verification panels, proficiency panels, customized, and OEM products/services.

NATtrol products are ready-to-use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance. NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.

Featured image: ZeptoMetrix NATtrol Bacteriophage MS2 quantitative stock: NATMS2-STQ is intended for use as an internal process control for molecular diagnostic assays. Photo: ZeptoMetrix